Trial intelligence / Profile preview

Efficacy of remimazolam tosilate vs propofol for general anesthesia in laparoscopic cholecystectomy

ChiCTR2300071256Phase 4Not yet recruiting

Sponsor
First People's Hospital of Zunyi
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in cholecystitis and cholelithiasis (2 arms), sponsored by First People's Hospital of Zunyi. Primary endpoints: Induction time, Extubation time and 2 more. Planned start May 2023; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

cholecystitischolelithiasis

Beyond the preview

Go deeper on ChiCTR2300071256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300071256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call